Company Description

ImmunoBiochem is on a mission to develop novel bioconjugate therapeutics, such ADCs, ISACs and DACs, to address significant unmet need in oncology, immuno-oncology and immunology. In precision oncology and immuno-oncology, ImmunoBiochem focuses on the discovery of novel tumor secretome-based targets utilizing a combination of high-throughput functional assays, mass spectrometry and AI/ML to unravel unique cancer biology.